Cryosa
PrivateLast Round
Series B
Sep 23, 2021
Total Funding Raised
$34.25M
Company Overview
Cryosa operates in Healthcare & Life Sciences and is based in Arden Hills, Minnesota. Its latest recorded funding round was a Series B round in September 2021.
Cryosa is a clinical-stage medical device company developing a minimally invasive, incisionless treatment for moderate to severe Obstructive Sleep Apnea (OSA).
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cryosa Comparables
Compare Cryosa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XII Medical | 91% | |
| Lunair Medical | 89% | |
| Restera | 89% |
For institutional investors. Book with your work email.
Cryosa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 23, 2021 | ||||
| Series A Extension | Jun 25, 2020 | ||||
| Series A | May 29, 2019 | ||||
| Series A | Apr 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cryosa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Santé Ventures | Series B, Series A Extension |
| Santé Ventures | Series B, Series A, Series A Extension |
| Solas BioVentures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2021
$22M round led by Solas BioVentures.
- Jun 25, 2020
$8.25M round led by Santé Ventures and HOYA Corporation.
For institutional investors. Book with your work email.
Cryosa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cryosa's valuation, stock price, and market status.
Is Cryosa a public or private company?
Cryosa is a private company.
What is the current stock price of Cryosa?
Cryosa is a private company, so its shares have no public market price. Caplight tracks Cryosa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cryosa worth (valuation)?
Valuation information for Cryosa is not publicly available.
Can I buy Cryosa stock?
Cryosa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cryosa's last funding round?
Cryosa's most recent funding round was Series B on September 23, 2021.
Who are the main investors in Cryosa?
Key investors in Cryosa include Santé Ventures, Santé Ventures, Solas BioVentures.
Will Cryosa IPO soon?
No public IPO plans have been announced for Cryosa.
How can I track Cryosa secondary market activity?
Caplight tracks bids, offers, and trades in Cryosa's shares on secondary markets.